Dividend Aristocrats In Focus: Abbott Laboratories
Updated on February 8th, 2021 by Nate Parsh Abbott Laboratories…
Read MoreESG opportunity can be meaningful for ILS: Nephila’s Schauble, ILS NYC 2021
Today, there’s a significant amount of capital looking to be…
Read MoreSwiss Re targets ILS business line expansion: Klugman & Johnson, ILS NYC 2021
Global reinsurance firm Swiss Re is working towards transferring a…
Read MoreTremor to “supercharge” reinsurance placement with Panorama launch
Tremor Technologies, the insurtech offering a technology-based programmatic insurance and…
Read MoreUS commercial property insurance rates decelerate in Q4: Marsh
Robust commercial property insurance price rises continued around the globe,…
Read MoreStrategic Risk Solutions launches Guernsey office, hires Child from Artex
Strategic Risk Solutions, Inc., a provider of insurance, reinsurance and…
Read MoreILS fulfils original purpose, should now target top risks: Hilti, ILS NYC 2021
Niklaus Hilti, Head of insurance-linked securities (ILS) at Credit Suisse…
Read MoreLongevity swap pricing to remain attractive in 2021: WTW
Longevity swap pricing is expected to remain attractive through the…
Read MoreBest of Artemis, week ending 7th February 2021
Here are the ten most popular news articles, week ending…
Read More